| 000 | 01671 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513174745.0 | ||
| 264 | 0 | _c19990415 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-199904000-00010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElias, L | |
| 245 | 0 | 0 |
_aPilot trial of infusional 5-fluorouracil, interleukin-2, and subcutaneous interferon-alpha for advanced renal cell carcinoma. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cApr 1999 |
||
| 300 |
_a156-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aBinder, M | |
| 700 | 1 | _aMangalik, A | |
| 700 | 1 | _aClark, D | |
| 700 | 1 | _aMorrison, B | |
| 700 | 1 | _aAltobelli, K K | |
| 700 | 1 | _aSmith, A | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 22 _gno. 2 _gp. 156-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199904000-00010 _zAvailable from publisher's website |
| 999 |
_c10158834 _d10158834 |
||